Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – What’s Next?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) gapped up before the market opened on Wednesday. The stock had previously closed at $6.23, but opened at $6.40. Coloplast A/S shares last traded at $6.38, with a volume of 2,890 shares traded.

Coloplast A/S Stock Up 0.6%

The company has a market cap of $14.39 billion, a price-to-earnings ratio of 33.61, a P/E/G ratio of 2.22 and a beta of 0.21. The stock’s 50-day moving average is $6.73 and its 200-day moving average is $6.45. The company has a current ratio of 1.56, a quick ratio of 0.94 and a debt-to-equity ratio of 1.51.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Tuesday, August 18th. The company reported $0.10 earnings per share for the quarter, meeting the consensus estimate of $0.10. The firm had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.11 billion. Coloplast A/S had a net margin of 9.68% and a return on equity of 39.27%. On average, analysts anticipate that Coloplast A/S Sponsored ADR will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.

The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management.

Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy.